Fish & Richardson has announced that 13 of its principals were named “Life Sciences Stars” for 2018 by LMG Life Sciences, a guide to the leading North American law firms and lawyers specializing in the life sciences industry. The firm also received the top “Highly recommended” ranking in the General Patent Litigation, Hatch-Waxman Patent Litigation (Branded), Patent Prosecution and Patent Strategy & Management categories. LMG Life Sciences highlighted Fish’s “significant breadth of experience to clients in all areas of the life sciences patent space.”
Lasts month, LMG Life Sciences also named Fish its 2018 General Patent Litigation Firm of the Year and the Intellectual Property Firm of the Year. Fish’s victory for Gilead Sciences in Idenix Pharmaceuticals et al. v. Gilead Sciences, Inc. was selected as the 2018 Patent Impact Case of the Year.
San Diego Fish attorneys Brooks, Shear and Singer where part of the trial team in the matter in which Fish wiped out a $2.5 billion patent verdict against client Gilead, the largest patent infringement verdict to date. Brooks and Singer were shortlisted for LMG Life Sciences’ 2018 General Patent Litigator of the Year in their regions for their work on the Gilead case, with Singer winning the award in California.
According to LMG Life Sciences, clients had high praise for Fish’s patent prosecution services, stating that the firm has “always lived up to their excellent reputation.
Other Fish principals from various offices throughout the U.S. were also named as Life Sciences Stars:
- Patent Group – Gwilym Attwell, Dr. Janis Fraser, Dr. Todd Garcia, Dr. Teresa Lavoie, and Dorothy Whelan
- IP Litigation Group – John Adkisson, Elizabeth Flanagan, Frank Scherkenbach, and Martina Tyreus Hufnal
- Regulatory Group – Terry Mahn
Fish’s Life Sciences group works with large and small companies, along with academic and research institutions, to protect their most valuable innovations. Clients choose Fish because of the technical and scientific expertise of its internationally-recognized attorneys. The firm offers biotechnology and pharmaceutical clients a wide range of services, including patent portfolio planning, strategic advice, opinions and prosecution; litigation services, including representing branded companies in Hatch-Waxman cases; representation in post-grant proceedings including inter partes reviews before the Patent Trial and Appeal Board; FDA expertise; and counsel on licensing and other transactions.
Fish & Richardson, a premier global intellectual property law firm, is sought-after and trusted by the world’s most innovative brands and influential technology leaders. Fish offers litigation, prosecution and counseling services for patents, trademarks and copyrights, as well as trade secret counseling and litigation services. Our deep bench of attorneys with first-chair trial experience in every technology makes us the go-to firm for the most technically complex cases. We have an established reputation as a top-tier firm for patent portfolio planning, strategy and prosecution, as well as post-grant proceedings at the PTAB. Established in 1878, and now with more than 400 attorneys and technology specialists in the U.S. and Europe, our success is rooted in our creative and inclusive culture, which values the diversity of people, experiences and perspectives. For more information, visit fr.com or follow us at@FishRichardson.